Method and device for separating whole blood into an erythrocyte concentrate and cell-free or thrombocyte-containing plasma under gravitational force
A technology of red blood cells and concentrates, which is applied in the field of red blood cell concentrates and plasma, and can solve problems such as technical complexity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example 1
[0097] Plasma separation was performed on 552 g of whole blood (hematocrit 40.8%) stored at 26° C. for 30 minutes after being drawn from blood donors. The whole blood was first passed through a leukocyte filter (LST1 from Maco Pharma), and more than 99.9% of leukocytes / platelets were removed in the leukocyte filter.
[0098] The plasma filter used was Hemaplex BT900 / C sold by Dideco.
[0099] The operating time was 30 minutes until the first stage of separation was completed. The hematocrit achieved in the first phase was 56.6%.
[0100] The distance a is 40cm (=0.4mWC), b=10cm, c=85cm.
[0101] Afterwards, the bag containing the first red blood cell concentrate solution is inverted and the second phase begins. This phase ends after 20 minutes. The resulting hematocrit was 72.1%. The hematocrit of the second erythrocyte concentrate solution was set to 41.4% by adding the supplement solution (313 g).
[0102] The net weights of the plasma and erythrocyte concentrates were...
example 2
[0105] Example 1 was repeated, first passing whole blood through a leukocyte filter and removing leukocytes outside of the filter system (see Figure 3). Then, plasma separation was performed at 32-26°C.
[0106] The operating time is about 10 ± 5 minutes until the end of the first separation. After the first separation step, the resulting hematocrit is about 55-65%.
[0107] The distance a reaches 100cm (=1mWC). The distance b is 10-20cm, and the distance c is 85-100cm.
[0108] Then, flip the bag over and reverse the direction of filtration. Thus begins the second phase. This phase ends after 15±5 minutes. A hematocrit of about 55-65% is obtained.
[0109] If passed through the device again, the hematocrit can increase to 80-85%. The resulting erythrocyte concentrate has a net weight of about 180-200 g.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com